Inspira Technologies Oxy B.H.N. LTD (IINNW) SEC Filings — 2024
42 SEC filings for Inspira Technologies Oxy B.H.N. LTD (IINNW) in 2024.
Filings
- Inspira Technologies Holds Annual Shareholder Meeting — 6-K · Dec 30, 2024
- Inspira Technologies Announces Private Placement — 6-K · Dec 27, 2024
- Inspira Technologies Delivers Systems for U.S. Deployment — 6-K · Dec 16, 2024
- Inspira Technologies Expands HYLA Blood Sensor Tech — 6-K · Dec 10, 2024
- Inspira Technologies Partners with Westchester Medical Center — 6-K · Dec 4, 2024
- Inspira Technologies Schedules Annual Meeting for Dec 30 — 6-K · Nov 25, 2024
- Inspira Technologies Oxy B.H.N. LTD SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Inspira Technologies Files 6-K with Website Presentation — 6-K · Nov 12, 2024
- Inspira Technologies Establishes U.S. Distribution Facility — 6-K · Oct 24, 2024
- Inspira Tech Develops New Disposable Kit with Monitoring — 6-K · Oct 9, 2024
- Inspira Technologies Secures Second U.S. Patent for Oxygen Delivery System — 6-K · Sep 13, 2024
- Inspira to Publish HYLA Clinical Results in Q4 2024 — 6-K · Aug 28, 2024
- Inspira Technologies FDA Listed, Market Ready New Product — 6-K · Aug 22, 2024
- Inspira Technologies Files 6-K with June 30 Financials — 6-K · Aug 15, 2024
- Inspira ART100 Shows Over 100% Performance in Medical Company Trial — 6-K · Aug 13, 2024
- Inspira Technologies Launches INSPIRA Cardi-ART for Cardiac Arrest — 6-K · Jul 30, 2024
- Inspira Technologies Gets Israeli Approval for ART100 System — 6-K · Jul 11, 2024
- Inspira Technologies Announces Business Plan Targets — 6-K · Jun 20, 2024
- Inspira Technologies Announces Registered Direct Offering — 6-K · Jun 17, 2024
- Inspira Technologies Secures First U.S. Purchase Order for ART100 Systems — 6-K · Jun 13, 2024
- Inspira Technologies ART100 Gets FDA 510(k) Clearance — 6-K · May 28, 2024
- Inspira Technologies Starts Production of INSPIRA ART100 — 6-K · May 2, 2024
- Inspira Technologies ART100 Gains U.S. CSA Certification — 6-K · Apr 25, 2024
- Inspira Technologies Signs Term Sheet for Organ Transplant Device Use — 6-K · Apr 17, 2024
- Inspira Tech Study Shows 100% Prevention of Bloodstream Infection Bacteria — 6-K · Apr 10, 2024
- Inspira Technologies Shareholders Approve All Agenda Items — 6-K · Apr 9, 2024
- Inspira Technologies Explores Artificial Womb Use for ART100 Device — 6-K · Apr 3, 2024
- Inspira Technologies Raises $1.65M in Share Offering — 6-K · Apr 1, 2024
- Inspira Technologies OXY B.H.N. Ltd Files 2024 Annual Report — 20-F · Mar 25, 2024
- Inspira Technologies submits ART100 for regulatory approval — 6-K · Mar 18, 2024
- Inspira Technologies Releases New Data on Core Technology — 6-K · Mar 12, 2024
- Inspira Technologies Schedules Shareholder Meeting for April 8 — 6-K · Mar 8, 2024
- Inspira Tech to Report Blood Oxygenation Results Soon — 6-K · Mar 4, 2024
- Inspira Nears FDA Approval, Secures $546M in Distribution Deals — 6-K · Feb 27, 2024
- Inspira Technologies Unveils New Bio-Mimicking Blood Platform — 6-K · Feb 22, 2024
- Inspira Technologies Secures First U.S. Patent for Blood Oxygenation System — 6-K · Feb 14, 2024
- Inspira Technologies Oxy B.H.N. LTD SC 13G Filing — SC 13G · Feb 14, 2024
- Joe Hayon Maintains 9.9% Stake in Inspira Technologies — SC 13G/A · Feb 12, 2024
- Inspira Technologies Partners for Clinical Evaluation of INSPIRA™ ART Device — 6-K · Feb 8, 2024
- Inspira Technologies Partners with Glo-Med for 531 ART Device Deployment in Gulf States — 6-K · Jan 30, 2024
- Inspira Tech to Launch Disposable Blood Oxygenation Kit — 6-K · Jan 9, 2024
- Inspira Tech Signs LOI with Northwestern Memorial for ART100 Device — 6-K · Jan 2, 2024